GlaxoSmithKline

US · GSK #230 by market cap Listed 1970

50.33 -0.08 -0.16%

Periodic snapshot; not a real-time feed. · 2026-11-06 19:30

✦ Quant Ownership Signal how this is computed

Distributing

The number of reporting institutions decreased by 28 in the most recent period (2026/Q3).
Total institutional ownership fell 0.6 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions: 87.88% -0.65pp
Institutions: 1,599 -28
As of: 2026/Q3 vs. prior period

Holder types

Mutual Fund72.95%

Private Company4.14%

Sovereign Wealth Fund3.18%

Public Company2.60%

Government Pension Fund1.82%

Corporate Pension Plan1.79%

Hedge Fund0.82%

Insurance Company0.25%

Government0.13%

Other12.31%

Top holders as of 2026-09-01

BlackRock 9.41% · 188.65M sh

Dodge & Cox 4.37% · 87.61M sh

Vanguard Capital Management, LLC 4.02% · 80.58M sh

FMR 3.48% · 69.84M sh

Wellington Management Group 2.82% · 56.60M sh

Other 75.57%

State Street Global Advisors 2.44% · 48.98M sh

Fisher Investments 2.19% · 43.91M sh

UBS Asset Management 2.12% · 42.40M sh

Strategic Advisers LLC 1.77% · 35.53M sh

GlaxoSmithKline Employee Trust 1.68% · 33.60M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

0 filings tracked · 0 buys · 0 sells

Quote time 2026-11-06 19:30:03 · For reference only, not investment advice and not tailored to your situation.